Paper Details

  1. Home
  2. Paper Details

Morphea secondary to interferon beta1b injection: a case and review of the literature.

Author: AkdenizNecmettin, KaradagAyse Serap, OzkanliSeyma, OzluEmin, UzuncakmakTugba Kevser, ZemheriEbru

Case ReportsIn the medical field, a report that describes in detail a unique case, an unusual medical condition, or the effect of a treatment. Provides new insights and possibilities for treatment through individual patient cases.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Interferon beta (IFNβ) is a common treatment for multiple sclerosis (MS) but can cause skin side effects. This case report describes a patient who developed morphea, a rare skin condition, after receiving IFNβ1b injections. This case highlights the importance of being aware of the potential for rare side effects, even with commonly used medications.
Paper Details　
Original Abstract of the Article :
Interferon beta (IFNβ) is a drug used successfully in the treatment of multiple sclerosis (MS). Although IFNβ is a safe and well-tolerated drug, dermatological side effects are common. The most common dermatological adverse effect is a local reaction at the injection site. It may also cause inflamma...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/31046913

データ提供：米国国立医学図書館（NLM）

Morphea Secondary to Interferon Beta1b Injection: A Rare Case

This research explores a rare case of morphea, a scleroderma-related condition characterized by thickened, hardened skin, developing as a side effect of interferon beta1b injections. This study sheds light on the potential dermatological side effects of interferon beta1b, a drug commonly used to treat multiple sclerosis.

The case report highlights the development of morphea in a patient receiving interferon beta1b injections for multiple sclerosis. While this is a rare occurrence, it underscores the importance of being aware of potential dermatological side effects associated with this medication. The study also reviews previous literature on interferon beta-induced dermatological reactions, providing a comprehensive overview of the possible adverse effects.

The research emphasizes the need for careful monitoring and management of potential dermatological side effects, particularly in patients receiving interferon beta1b injections. This could involve regular skin examinations and prompt intervention if any signs of morphea or other skin abnormalities arise.

The Importance of Early Detection

This case report underscores the importance of early detection in managing potential side effects of medications. Like a camel carefully navigating a desert, we must be vigilant in monitoring for any unusual signs or symptoms, especially when taking medications. This can help ensure that any potential issues are addressed promptly, potentially preventing more serious complications.

A Deeper Understanding of Interferon Beta1b Side Effects

This research adds to our understanding of the potential dermatological side effects associated with interferon beta1b, a valuable drug for managing multiple sclerosis. It highlights the importance of being aware of these risks and underscores the need for careful monitoring to ensure patient safety and well-being.

Dr. Camel's Conclusion

This study provides a valuable reminder of the importance of being aware of potential side effects associated with medications, even those that are generally considered safe and effective. Like a camel carefully navigating a vast and unforgiving desert, we must be vigilant in our pursuit of health, paying close attention to any unusual signs or symptoms.

Date :
  1. Date Completed 2019-12-06
  2. Date Revised 2019-12-17
Further Info :

Pubmed ID

31046913

DOI: Digital Object Identifier

31046913

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.